Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial.

[1]  W. P. Dixon,et al.  BMPD statistical software manual , 1988 .

[2]  Dwight E. Peake,et al.  Thrombolysis in myocardial infarction (TIMI) trial: Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase , 1988 .

[3]  R Roberts,et al.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. , 1987, Circulation.

[4]  F H Sheehan,et al.  The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. , 1987, Circulation.

[5]  Harold T. Dodge,et al.  Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase* , 1987 .

[6]  H. Gold,et al.  Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosis. , 1986, The American journal of cardiology.

[7]  M. Gotsman,et al.  Importance of early initiation of intravenous streptokinase therapy for acute myocardial infarction. , 1986, The American journal of cardiology.

[8]  G. Taylor,et al.  Thrombolytic therapy followed by early revascularization for acute myocardial infarction. , 1986, The American journal of cardiology.

[9]  B. Pitt,et al.  A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. , 1986, The New England journal of medicine.

[10]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[11]  M. Gotsman,et al.  Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. , 1985, The New England journal of medicine.

[12]  S. Sherry.  Tissue plasminogen activator (t-PA). Will it fulfill its promise? , 1985, The New England journal of medicine.

[13]  F. Sheehan,et al.  Time from onset of symptoms to thrombolytic therapy: a major determinant of myocardial salvage in patients with acute transmural infarction. , 1985, Journal of the American College of Cardiology.

[14]  D. Holmes,et al.  Percutaneous transluminal coronary angioplasty, alone or in combination with streptokinase therapy, during acute myocardial infarction. , 1985, Mayo Clinic proceedings.

[15]  J. Hirsh,et al.  A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits. , 1985, Circulation.

[16]  E. Braunwald.  The aggressive treatment of acute myocardial infarction. , 1985, Circulation.

[17]  J. Arciniegas,et al.  Percutaneous transluminal coronary angioplasty after intracoronary streptokinase in evolving acute myocardial infarction. , 1985, The American journal of cardiology.

[18]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.

[19]  J. Matloff,et al.  The role of cardiac surgery in acute myocardial infarction. I. With mechanical complications. , 1983, American heart journal.

[20]  M. Ter-pogossian,et al.  Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. , 1982, The American journal of medicine.

[21]  P. Rentrop,et al.  Changes in left ventricular function after intracoronary streptokinase infusion in clinically evolving myocardial infarction. , 1981, American heart journal.

[22]  M. Dewood,et al.  Medical and surgical management of myocardial infarction. , 1979, The American journal of cardiology.

[23]  L. Cohn,et al.  Aorto-coronary bypass for acute coronary occlusion. , 1972, The Journal of thoracic and cardiovascular surgery.